Holen Sie sich die Stockscreener-App
10.00
1.57%
-0.16
Handel nachbörslich:
10.05
0.05
+0.50%
Schlusskurs vom Vortag:
$10.16
Offen:
$10.3
24-Stunden-Volumen:
2.55M
Relative Volume:
0.96
Marktkapitalisierung:
$1.15B
Einnahmen:
$2.35B
Nettoeinkommen (Verlust:
$-74.42M
KGV:
-10.64
EPS:
-0.94
Netto-Cashflow:
$150.93M
1W Leistung:
-20.26%
1M Leistung:
-8.00%
6M Leistung:
-52.04%
1J Leistung:
-67.27%
1-Tages-Spanne:
$9.96
$10.47
1-Wochen-Bereich:
$9.88
$12.78
52-Wochen-Spanne:
$9.88
$35.00
Evolent Health Inc Stock (EVH) Company Profile
Firmenname
Evolent Health Inc
Sektor
Branche
Telefon
571-389-6000
Adresse
800 NORTH GLEBE RD, SUITE 500, ARLINGTON
Vergleichen Sie EVH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
EVH
Evolent Health Inc
|
10.00 | 1.15B | 2.35B | -74.42M | 150.93M | -0.94 |
|
VEEV
Veeva Systems Inc
|
216.59 | 35.16B | 2.66B | 665.91M | 1.08B | 4.05 |
|
SOLV
Solventum Corp
|
73.51 | 12.70B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
DOCS
Doximity Inc
|
53.72 | 10.03B | 516.85M | 174.11M | 217.38M | 0.87 |
|
HQY
Healthequity Inc
|
102.42 | 8.88B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
37.47 | 6.45B | 906.14M | -52.62M | 89.62M | -0.3621 |
Evolent Health Inc Stock (EVH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-10 | Eingeleitet | Needham | Buy |
| 2024-12-03 | Bestätigt | BTIG Research | Buy |
| 2024-11-08 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2024-08-09 | Hochstufung | Truist | Hold → Buy |
| 2024-04-22 | Eingeleitet | Citigroup | Buy |
| 2024-03-01 | Eingeleitet | Oppenheimer | Outperform |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-12-06 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-10-16 | Eingeleitet | UBS | Buy |
| 2023-04-12 | Eingeleitet | Stephens | Overweight |
| 2022-11-01 | Eingeleitet | Truist | Hold |
| 2022-07-29 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-03-30 | Eingeleitet | Guggenheim | Buy |
| 2021-11-18 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2021-04-29 | Fortgesetzt | JP Morgan | Neutral |
| 2021-01-07 | Eingeleitet | BTIG Research | Buy |
| 2020-07-06 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-06-05 | Herabstufung | Goldman | Buy → Neutral |
| 2020-06-02 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2018-10-05 | Fortgesetzt | Leerink Partners | Outperform |
| 2018-06-04 | Eingeleitet | Piper Jaffray | Overweight |
| 2018-04-24 | Fortgesetzt | JP Morgan | Neutral |
| 2017-09-20 | Eingeleitet | KeyBanc Capital Mkts | Overweight |
| 2017-06-02 | Eingeleitet | Robert W. Baird | Outperform |
| 2017-03-14 | Eingeleitet | Oppenheimer | Outperform |
| 2017-01-13 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2016-10-28 | Fortgesetzt | JP Morgan | Overweight |
| 2016-08-05 | Bestätigt | FBR Capital | Outperform |
| 2016-07-26 | Eingeleitet | Jefferies | Buy |
| 2016-07-13 | Bestätigt | FBR Capital | Outperform |
| 2016-03-29 | Eingeleitet | FBR Capital | Outperform |
| 2016-01-06 | Eingeleitet | Canaccord Genuity | Buy |
| 2015-06-30 | Eingeleitet | Goldman | Buy |
| 2015-06-30 | Eingeleitet | JP Morgan | Overweight |
| 2015-06-30 | Eingeleitet | Leerink Partners | Outperform |
| 2015-06-30 | Eingeleitet | Sun Trust Rbsn Humphrey | Buy |
Alle ansehen
Evolent Health Inc Aktie (EVH) Neueste Nachrichten
Evolent Health (NYSE:EVH) Sees Unusually-High Trading VolumeTime to Buy? - MarketBeat
Evolent Health (NYSE:EVH) Price Target Lowered to $14.00 at UBS Group - MarketBeat
Evolent Health FY2024 EPS Estimate Boosted by William Blair - Defense World
Evolent Health FY2024 EPS Forecast Lifted by William Blair - MarketBeat
Evolent Health (NYSE:EVH) Reaches New 12-Month LowHere's Why - MarketBeat
Evolent Health Stock Price (NYSE: EVH) Hit 52 Week Lows as Guidance Falls Short - AskTraders
Evolent Health (NYSE:EVH) Shares Down 2% After Analyst Downgrade - Defense World
Evolent Health (NYSE:EVH) Stock Price Down 2% Following Analyst Downgrade - MarketBeat
Evolent Health stock hits 52-week low at $10.52 amid market challenges - Investing.com
What Analysts Are Saying About Evolent Health Stock - Benzinga
Evolent Health (NYSE:EVH) Sees Strong Trading VolumeShould You Buy? - MarketBeat
Evolent Health (NYSE:EVH) Price Target Cut to $17.00 by Analysts at Royal Bank of Canada - MarketBeat
RBC adjusts Evolent Health price target, praises strong re-contracting efforts - Investing.com UK
Evolent Health (FRA:9EH) Change In Receivables : €-17 Mil (TTM As of Sep. 2024) - GuruFocus.com
Evolent Health (NYSE:EVH) Given New $20.00 Price Target at Truist Financial - Defense World
Evolent Health to Present at J.P. Morgan Conference - TipRanks
Salem Investment Counselors Inc. Raises Stake in Evolent Health, Inc. (NYSE:EVH) - MarketBeat
Truist Financial Lowers Evolent Health (NYSE:EVH) Price Target to $20.00 - MarketBeat
Nordea Investment Management AB Grows Stake in Evolent Health, Inc. (NYSE:EVH) - Defense World
Dr. Abeer AbouYabis Scholarship for Future Doctors Inspires Aspiring Physicians to Tackle Healthcare Challenges - GlobeNewswire Inc.
Evolent Health (NYSE:EVH) Coverage Initiated at Needham & Company LLC - Defense World
JMP Securities Lowers Evolent Health (NYSE:EVH) Price Target to $18.00 - Defense World
Citigroup Issues Pessimistic Forecast for Evolent Health (NYSE:EVH) Stock Price - Defense World
Needham initiates Evolent Health stock with Buy rating, says it's undervalued - Investing.com Canada
Evolent Health's SWOT analysis: stock faces headwinds but analysts see long-term value - Investing.com India
Evolent Health's SWOT analysis: stock faces headwinds but analysts see long-term value By Investing.com - Investing.com South Africa
Citigroup Lowers Evolent Health (NYSE:EVH) Price Target to $18.00 - MarketBeat
Evolent Health, Inc. (NYSE:EVH) Shares Acquired by Harbor Capital Advisors Inc. - MarketBeat
JMP Securities Issues Pessimistic Forecast for Evolent Health (NYSE:EVH) Stock Price - MarketBeat
Needham & Company LLC Initiates Coverage on Evolent Health (NYSE:EVH) - MarketBeat
Needham Initiates Coverage of Evolent Health (EVH) with Buy Recommendation - MSN
High Growth Tech Stocks In The United States To Watch - Simply Wall St
We Think Evolent Health (NYSE:EVH) Can Stay On Top Of Its Debt - Simply Wall St
Evolent Health Inc (EVH) Stock Price Up 3.38% on Jan 2 - GuruFocus.com
Evolent Health, Inc. (NYSE:EVH): Are Analysts Optimistic? - Yahoo Finance
Short Interest in Evolent Health, Inc. (NYSE:EVH) Drops By 7.1% - MarketBeat
Citigroup Initiates Coverage of Evolent Health (EVH) with Buy Recommendation - MSN
Evolent Health, Inc. (NYSE:EVH) Receives Average Rating of "Buy" from Analysts - MarketBeat
Geode Capital Management LLC Sells 80,757 Shares of Evolent Health, Inc. (NYSE:EVH) - MarketBeat
Franklin Resources Inc. Boosts Stock Position in Evolent Health, Inc. (NYSE:EVH) - MarketBeat
Evolent Health (NYSE:EVH) Trading 4.9% HigherHere's Why - MarketBeat
Evolent Health, Inc. (NYSE:EVH) Shares Acquired by Barclays PLC - MarketBeat
Evolent to Appoint Dr. Von Nguyen as Incoming Chief Medical Officer - citybiz
Evolent announces Dr. Von Nguyen as incoming Chief Medical Officer, effective January 1 - The Malaysian Reserve
Evolent Health (EVH) Appoints Dr. Von Nguyen as incoming Chief Medical Officer - StreetInsider.com
Hedge Funds Think That Evolent Health, Inc. (EVH) Will Bounce Back Soon - Insider Monkey
Evolent Health stock hits 52-week low at $10.8 amid market challenges - Investing.com Canada
Evolent Health stock hits 52-week low at $10.8 amid market challenges By Investing.com - Investing.com South Africa
Evolent Health's SWOT analysis: growth prospects amid healthcare cost pressures - Investing.com India
Evolent Health secures new $250 million financing By Investing.com - Investing.com Nigeria
Finanzdaten der Evolent Health Inc-Aktie (EVH)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.02%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):